Are you Dr. Brennan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 76 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2102 Harrisburg Pike
Lancaster, PA 17601Phone+1 717-544-9400Fax+1 717-544-9401
Summary
- Dr. Matthew Brennan, MD is a hematologist in Lancaster, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Penn Medicine Lancaster General Health.
Education & Training
- Penn State Milton S Hershey Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2009 - 2012
- Pennsylvania State University College of MedicineClass of 2009
Certifications & Licensure
- PA State Medical License 2009 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 33 citationsOff-label use of cetuximab plus sorafenib and panitumumab plus regorafenib to personalize therapy for a patient with V600E BRAF-mutant metastatic colon cancer.Mhd Yaser Al-Marrawi, Bikramajit Singh Saroya, Matthew Brennan, Zhaohai Yang, Thomas M. Dykes
Cancer Biology & Therapy. 2013-06-13 - 624 citationsAssociation of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.Timothy J. Brown, Matthew Brennan, Michael Li, Ephraim W. Church, Nicholas J. Brandmeir
JAMA Oncology. 2016-11-01 - 2 citationsSuccessful Use of Rituximab and Intravenous Gamma Globulin to Treat Checkpoint Inhibitor- Induced Severe Lichen Planus Pemphigoides.Matthew Brennan, Marisa Baldissano, Lauren King, Anthony A. Gaspari
Skinmed. 2020-08-01
Press Mentions
- A Community Hospital Is a Destination for Advanced Cancer CareOctober 5th, 2023